go to contents go to 1depth menu
Aiming to be a global drug maker

RESEARCH AREA

inno.N studies various fields.

IN-A003,
IN-A005,
IN-A006,
IN-A007,
IN-A008 IN-A002 IN-A004,
IN-A009,
IN-A010 IN-A001 IN-A011,
IN-A012
NCE Etc. Oncology Auto immune
disease Non-
alcoholic steatohepatitis Gastro
esophageal reflux disease

Based on experience and know-how in new drug development, inno.N has developed the new drug 'K-CAB Tab.', a new drug for gastroesophageal reflux disease in Korea. We are expanding the pipeline by focusing on digestive, cancer, and immune diseases with high market unmet needs. In addition, we are continuing to “Open Innovation” with excellent R & D venture companies in Korea, Japan, the US and Europe to speed up the development of promising new drugs while expanding the R & D network.